Meyer Elbaz

Acute Myocardial Infarction

Étienne Puymirat, Tabassome Simon, Guillaume Cayla et al. · Circulation · 2017 · 525 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease

Julien Faccini, Jean‐Bernard Ruidavets, Pierre Cordelier et al. · Scientific Reports · 2017 · 141 citations · Full text

Medicine, Cardiology, Molecular Medicine +17

Role for Matrix Metalloproteinase-2 in Oxidized Low-Density Lipoprotein–Induced Activation of the Sphingomyelin/Ceramide Pathway and Smooth Muscle Cell Proliferation

Nathalie Augè, Françoise Maupas‐Schwalm, Meyer Elbaz et al. · Circulation · 2004 · 140 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16